JK
James Kihara sold $114K of ACAD stock
James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals Inc (ACAD), sold 5,401 shares of ACAD stock worth $114K, per an SEC Form 4 filed May 27, 2026.
It was an open-market sale.
The trade happened on May 26, 2026, 1 day before it was made public.
ACAD has moved -19.5% since the trade date, from $21.26 to $17.11 (Nov 20, 2026 close).
- Traded
- May 26, 2026
- Disclosed
- May 27, 2026
- Filing delay
- 1 day
- Price since
- -19.5%
- Role
- Principal Accounting Officer
- Source
- SEC Form 4